Claire Rosean Director, Translational Research Ms. Rosean has over 18 years of experience in basic and translational immuno-oncology research. Her scientific career spans a broad range of immune‑based therapeutic development, ...
Mark Eickhoff Senior Director, Operations Mark Eickhoff joined Immunomic Therapeutics with over 20 years of progressive leadership experience in clinical operations, with a specialized focus in vaccine development. Throughout his ...
Dong-Gun Kim Chief Executive Officer Dong-Gun (DG) Kim became CEO of Immunomic Therapeutics in 2023 after serving on the Company’s Board and as CEO of HLB from 2020. Before joining ...
Cara Sholter VP, Quality Assurance Cara Sholter joined Immunomic Therapeutics, Inc. in April 2021. She has over 20 years of progressive expertise across all GxP areas in the highly regulated ...
Erin Duffy Vice President, Finance Erin Duffy joined Immunomic Therapeutics in 2020. With over 30+ years experience, Ms. Duffy has addressed a wide array of financial issues, including IPOs, mergers ...
Teri Heiland, Ph.D. Chief Scientific Officer & Co-Founder Dr. Teri Heiland is the Chief Scientific Officer at Immunomic Therapeutics and Co-Founder of the Company. She has over 20 years of senior ...